Biotech & Health Tech
STAT+: Blackstone backs Pfizer’s bet on monthly obesity treatment
Pfizer spent up to $10 billion to buy Metsera last year. Now, it’s bringing in private equity behemoth Blackstone to help pay for the deal.
Pfizer spent up to $10 billion to buy Metsera last year. Now, it’s bringing in private equity behemoth Blackstone to help pay for the deal.
This is a summary of the story. Read the full article at Stat News (Biotech & Health Tech) ↗